IL315842A - תולדות פירידו-[4,3-d]פירידאזין אמין שימושיות כתולדות nlrp3 - Google Patents

תולדות פירידו-[4,3-d]פירידאזין אמין שימושיות כתולדות nlrp3

Info

Publication number
IL315842A
IL315842A IL315842A IL31584224A IL315842A IL 315842 A IL315842 A IL 315842A IL 315842 A IL315842 A IL 315842A IL 31584224 A IL31584224 A IL 31584224A IL 315842 A IL315842 A IL 315842A
Authority
IL
Israel
Prior art keywords
derivatives
nlrp3
pyrido
useful
pyridazine amine
Prior art date
Application number
IL315842A
Other languages
English (en)
Original Assignee
Ventus Therapeutics U S Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/704,983 external-priority patent/US11618751B1/en
Application filed by Ventus Therapeutics U S Inc filed Critical Ventus Therapeutics U S Inc
Publication of IL315842A publication Critical patent/IL315842A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL315842A 2022-03-25 2023-03-24 תולדות פירידו-[4,3-d]פירידאזין אמין שימושיות כתולדות nlrp3 IL315842A (he)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17/704,983 US11618751B1 (en) 2022-03-25 2022-03-25 Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
US202263420930P 2022-10-31 2022-10-31
US202363443874P 2023-02-07 2023-02-07
PCT/US2023/064967 WO2023183943A1 (en) 2022-03-25 2023-03-24 Pyrido-[3,4-d]pyridazine amine derivatives useful as nlrp3 derivatives

Publications (1)

Publication Number Publication Date
IL315842A true IL315842A (he) 2024-11-01

Family

ID=86329581

Family Applications (1)

Application Number Title Priority Date Filing Date
IL315842A IL315842A (he) 2022-03-25 2023-03-24 תולדות פירידו-[4,3-d]פירידאזין אמין שימושיות כתולדות nlrp3

Country Status (13)

Country Link
EP (1) EP4499638A1 (he)
JP (1) JP2025510414A (he)
KR (1) KR20250005125A (he)
CN (1) CN119137121A (he)
AU (1) AU2023238121A1 (he)
CA (1) CA3246681A1 (he)
CL (1) CL2024002855A1 (he)
CO (1) CO2024013702A2 (he)
IL (1) IL315842A (he)
MX (1) MX2024011697A (he)
PE (1) PE20250605A1 (he)
TW (1) TW202345836A (he)
WO (1) WO2023183943A1 (he)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
KR20240019083A (ko) 2021-06-04 2024-02-14 에프. 호프만-라 로슈 아게 트리아진 유도체 및 암 치료에서 이의 용도
US12331048B2 (en) 2022-10-31 2025-06-17 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
KR20250106322A (ko) * 2022-12-28 2025-07-09 장춘 진사이언스 파마슈티컬 씨오., 엘티디. 피리다진계 nlrp3 억제제 화합물, 약학 조성물 및 이의 제조 방법과 용도
WO2025059481A1 (en) 2023-09-13 2025-03-20 Ventus Therapeutics U.S., Inc. Solid forms of an nlrp3 inhibitor and uses thereof
WO2025153532A1 (en) 2024-01-16 2025-07-24 NodThera Limited Nlrp3 inhibitors and glp-1 agonists combination therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY38687A (es) * 2019-05-17 2023-05-15 Novartis Ag Inhibidores del inflamasoma nlrp3, composiciones, combinaciones de los mismos y métodos para su uso
US11618751B1 (en) * 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
US11319319B1 (en) * 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
IL310992A (he) * 2021-08-25 2024-04-01 Ptc Therapeutics Inc מעכבי nlrp3

Also Published As

Publication number Publication date
JP2025510414A (ja) 2025-04-14
AU2023238121A1 (en) 2024-10-10
EP4499638A1 (en) 2025-02-05
CL2024002855A1 (es) 2025-02-14
MX2024011697A (es) 2024-11-08
TW202345836A (zh) 2023-12-01
CN119137121A (zh) 2024-12-13
CA3246681A1 (en) 2023-09-28
WO2023183943A1 (en) 2023-09-28
KR20250005125A (ko) 2025-01-09
CO2024013702A2 (es) 2024-11-08
PE20250605A1 (es) 2025-02-26

Similar Documents

Publication Publication Date Title
IL315842A (he) תולדות פירידו-[4,3-d]פירידאזין אמין שימושיות כתולדות nlrp3
IL284228A (he) מעכבי imidazo[1,2-b]pyridazine il-17a
HUE070805T2 (hu) [1,3]diazino[5,4-D]pirimidenek, mint HER2-gátlók
ZA202105338B (en) Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as tlr7 agonist
IL162461A0 (en) Polymorphs of clopidogrel hydrogensulfate
NZ744349A (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors
WO2008058126A3 (en) Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
DK1534707T3 (da) Substituerede 2,4-dihydropyrrolo[3,4-b]quinolin-9-on-derivater egnede som phosphodiesteraseinhibitorer
ZA202100259B (en) Pyrrolo[1,2-b]pyridazine derivatives
IL306083A (he) תולדות 3H, 4H – תיאנו[3,2-d]פירימידין-4-און כמעכבי TRPA1
EP4267581A4 (en) SUBSTITUTED IMIDAZO[1,5-B PYRIDAZINE COMPOUNDS AS KINASE INHIBITORS AND THEIR USE
IL280122A (he) נגזרות אימידאזו[2,1-b]פירידאזין כמעכבי trk
WO2003059911A3 (en) 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS
HK40115432A (en) Pyrido-[3,4-d]pyridazine amine derivatives useful as nlrp3 derivatives
EP4175957A4 (en) 2,3-DISUBSTITUTED PYRIDO[3,4-B!PYRAZINE-CONTAINING COMPOUNDS AS KINASE INHIBITORS
HUE073369T2 (hu) Pirido[2,3-e]oxazin-származékok, mint mezõgazdasági kemikáliák
ZA202406459B (en) Pyrido[1,2-a]pyrimidin-4-one derivatives
GB202407386D0 (en) 1H-pyrazolo(4,3-D)pyrimidine derivatives
HK40063512A (en) Imidazo [2, 1-f] [1, 2, 4] triazin-4-amine derivatives as tlr7 agonist
HK40101090A (en) Pyrazolo[3,4-d]pyrimidin-6-yl-sulfonamide derivatives for the inhibition of sgk-1
CA3287880A1 (en) Pyrido[4,3-d]pyrimidine compounds
IL175957A0 (en) Novel crystalline forms of 2,3 dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt
CA3286684A1 (en) Imidazo[1,2-a]pyrazine derivatives
CA3287799A1 (en) Imidazo[1,2-a]pyrazine derivatives
HK40119922A (en) Imidazo(1,2-a)pyridine derivatives as ripk2 inhibitors